Reliability of Subcutaneous Echogenicity (SEG) Grade and Subcutaneous Echo-free Space (SEFS) Grade
The Inter- and Intra-rater Reliability of Subcutaneous Echogenicity (SEG) Grade and Subcutaneous Echo-free Space (SEFS) Grade in Postmastectomy Lymphedema
1 other identifier
observational
50
1 country
1
Brief Summary
The aims of this study is to determine the inter- and intra-rater reliability of SEG and SEFS grade systems for postmastectomy lymphedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2018
CompletedFirst Posted
Study publicly available on registry
June 18, 2018
CompletedStudy Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2018
CompletedAugust 23, 2018
August 1, 2018
1 month
June 6, 2018
August 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
International Society of Lymphology (ISL) stage by rater 1
stage of the clinical severity of lymphedema
Day 0
International Society of Lymphology (ISL) stage by rater 1
stage of the clinical severity of lymphedema
Day 3
International Society of Lymphology (ISL) stage by rater 2
stage of the clinical severity of lymphedema
Day 0
Secondary Outcomes (18)
MCP joint level affected arm
Day 0
MCP joint level unaffected arm
Day 0
wrist joint level affected arm
Day 0
wrist joint level unaffected arm
Day 0
15 cm below the elbow joint point affected arm
Day 0
- +13 more secondary outcomes
Study Arms (1)
Study Group
patients with postmastectomy lymphedema who will undergo ultrasonographic assessment of postmastectomy lymphedema and circumferential tape measurement of arm
Interventions
Qualitative assessment of postmastectomy lymphedema via ultrasound (Subcutaneous echogenicity (SEG) and subcutaneous echo-free space (SEFS) grade systems for postmastectomy lymphedema) and circumferential tape measures ( The circumferential measurement of affected arm at MCP joint, wrist joint, 15 below elbow joint, elbow joint 15cm above elbow point) to assess upper extremity volume
Eligibility Criteria
Women with postmastectomy lymphedema aged 18-65 years old
You may qualify if:
- \. Patients with unilateral postmastectomy lymphedema
You may not qualify if:
- Bilateral lymphedema
- The patients who had known systemic edemagenic conditions (e.g., cardiac/hepatic/renal failure, terminal cancer, on chemotherapy), and/or with cancer recurrence were excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University School of Medicine Department of Physical Medicine and Rehabilitation
Istanbul, 34899, Turkey (Türkiye)
Related Publications (1)
Giray E, Yagci I. Interrater and Intrarater Reliability of Subcutaneous Echogenicity Grade and Subcutaneous Echo-Free Space Grade in Breast Cancer-Related Lymphedema. Lymphat Res Biol. 2019 Oct;17(5):518-524. doi: 10.1089/lrb.2018.0053. Epub 2018 Dec 20.
PMID: 30570358DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
İlker Yagci, Prof, Msc
Marmara University
- PRINCIPAL INVESTIGATOR
Esra Giray, MD
Marmara University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2018
First Posted
June 18, 2018
Study Start
July 1, 2018
Primary Completion
August 13, 2018
Study Completion
August 13, 2018
Last Updated
August 23, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share
We don't plan to share.